COSCIENS Biopharma (CSCI) Revenue & Revenue Breakdown
COSCIENS Biopharma Revenue Highlights
Latest Revenue (Y)
$9.13M
Latest Revenue (Q)
$1.50M
COSCIENS Biopharma Revenue by Period
COSCIENS Biopharma Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $9.13M | 27.77% |
| 2023-12-31 | $7.14M | -50.98% |
| 2022-12-31 | $14.57M | 8.05% |
| 2021-12-31 | $13.49M | 13.73% |
| 2020-12-31 | $11.86M | 20.27% |
| 2019-12-31 | $9.86M | 15.85% |
| 2018-12-31 | $8.51M | -17.20% |
| 2017-12-31 | $10.28M | 1.04% |
| 2016-12-31 | $10.17M | 32.34% |
| 2015-12-31 | $7.69M | 0.38% |
| 2014-12-31 | $7.66M | 24.99% |
| 2013-12-31 | $6.13M | 18.01% |
| 2012-12-31 | $5.19M | -8.38% |
| 2011-12-31 | $5.67M | 1.64% |
| 2010-12-31 | $5.58M | - |
COSCIENS Biopharma generated $9.13M in revenue during NA 2024, up 27.77% compared to the previous quarter, and up 92.56% compared to the same period a year ago.
COSCIENS Biopharma Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-03-31 | $1.50M | -54.98% |
| 2024-12-31 | $3.32M | 77.55% |
| 2024-09-30 | $1.87M | -19.94% |
| 2024-06-30 | $2.34M | 13.84% |
| 2024-03-31 | $2.05M | 47.77% |
| 2023-12-31 | $1.39M | -28.83% |
| 2023-09-30 | $1.95M | 40.23% |
| 2023-06-30 | $1.39M | -46.13% |
| 2023-03-31 | $2.58M | 1.94% |
| 2022-12-31 | $2.53M | -9.86% |
| 2022-09-30 | $2.81M | -34.13% |
| 2022-06-30 | $4.27M | -13.65% |
| 2022-03-31 | $4.94M | 76.68% |
| 2021-12-31 | $2.80M | -21.10% |
| 2021-09-30 | $3.55M | -0.27% |
| 2021-06-30 | $3.56M | -4.54% |
| 2021-03-31 | $3.72M | 44.18% |
| 2020-12-31 | $2.58M | -0.50% |
| 2020-09-30 | $2.60M | -24.00% |
| 2020-06-30 | $3.42M | 13.38% |
| 2020-03-31 | $3.01M | 2.43% |
| 2019-12-31 | $2.94M | 33.91% |
| 2019-09-30 | $2.20M | -5.56% |
| 2019-06-30 | $2.33M | -2.85% |
| 2019-03-31 | $2.39M | -20.09% |
| 2018-12-31 | $3.00M | 82.22% |
| 2018-09-30 | $1.64M | -20.82% |
| 2018-06-30 | $2.08M | 18.17% |
| 2018-03-31 | $1.76M | -21.98% |
| 2017-12-31 | $2.25M | -22.38% |
| 2017-09-30 | $2.90M | 18.95% |
| 2017-06-30 | $2.44M | 2.21% |
| 2017-03-31 | $2.39M | 47.61% |
| 2016-12-31 | $1.62M | -29.54% |
| 2016-09-30 | $2.30M | -28.75% |
| 2016-06-30 | $3.22M | 2.90% |
| 2016-03-31 | $3.13M | 36.14% |
| 2015-12-31 | $2.30M | 0.26% |
| 2015-09-30 | $2.29M | 16.71% |
| 2015-06-30 | $1.97M | 45.32% |
| 2015-03-31 | $1.35M | -12.09% |
| 2014-12-31 | $1.54M | -29.77% |
| 2014-09-30 | $2.19M | -3.90% |
| 2014-06-30 | $2.28M | 28.92% |
| 2014-03-31 | $1.77M | 40.44% |
| 2013-12-31 | $1.26M | -34.98% |
| 2013-09-30 | $1.94M | 101.25% |
| 2013-06-30 | $962.14K | -51.35% |
| 2013-03-31 | $1.98M | 69.64% |
| 2012-12-31 | $1.17M | -10.57% |
| 2012-09-30 | $1.30M | -11.01% |
| 2012-06-30 | $1.47M | 22.88% |
| 2012-03-31 | $1.19M | -24.87% |
| 2011-12-31 | $1.59M | 8.68% |
| 2011-09-30 | $1.46M | 19.28% |
| 2011-06-30 | $1.22M | -22.43% |
| 2011-03-31 | $1.58M | -13.01% |
| 2010-12-31 | $1.81M | 9.58% |
| 2010-09-30 | $1.66M | 71.33% |
| 2010-06-30 | $966.21K | - |
COSCIENS Biopharma generated $1.50M in revenue during Q1 2025, up -54.98% compared to the previous quarter, and up 107.65% compared to the same period a year ago.